Chemoinformaics analysis of (2S)-2-AMINO-3-(2,4-DIOXO-1H-PYRIMIDIN-3-YL)PROPANOIC ACID
| Molecular Weight | 199.166 | nRot | 3 |
| Heavy Atom Molecular Weight | 190.094 | nRig | 16 |
| Exact Molecular Weight | 199.059 | nRing | 1 |
| Solubility: LogS | -1.709 | nHRing | 1 |
| Solubility: LogP | 1.903 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 24.1991 |
| nHD | 3 | BPOL | 13.3429 |
| QED | 0.858 |
| Synth | 3.903 |
| Natural Product Likeliness | 0.872 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.067 |
| HIA | 0.382 |
| CACO-2 | -4.925 |
| MDCK | 0.0000207 |
| BBB | 0.302 |
| PPB | 0.40379 |
| VDSS | 2.69 |
| FU | 0.604868 |
| CYP1A2-inh | 0.039 |
| CYP1A2-sub | 0.073 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.785 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.087 |
| CYP2d6-inh | 0.92 |
| CYP2d6-sub | 0.812 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.729 |
| CL | 12.157 |
| T12 | 0.553 |
| hERG | 0.758 |
| Ames | 0.023 |
| ROA | 0.041 |
| SkinSen | 0.665 |
| Carcinogencity | 0.075 |
| EI | 0.015 |
| Respiratory | 0.854 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.857582 |